Medical Abortion Clinical Trial
Official title:
Can Midlevel Providers Manage Medical Abortion in the Second Trimester as Safely and Effectively as Physicians? A Randomized Controlled Trial in Ethiopia
The purpose of the study is to determine the safety and effectiveness of second trimester medical abortion when provided by nurse midwives compared with physicians. The study sample will be obtained from Michu Clinic, affiliated with St Paul's hospital, in Addis Ababa.
About 10% of all abortions globally take place at or after 13 weeks gestation. Women seeking second-trimester abortion services are often the most vulnerable and socially disadvantaged population.Studies show the rate of second-trimester abortion procedures remains stable over time, even in high-access locations, confirming the ongoing need for accessibility to services in rural locations with limited access to care. In Ethiopia, second-trimester abortion services are widely available in Addis Ababa, making up a high proportion of the total number of abortions occurring each year in the country; however, access to accurate and reliable data is limited. The World Health Organization recommends that abortion can be provided at the lowest level of the healthcare system (WHO abortion guidelines). Training mid-level providers, such as midwives, nurses and other non-physician providers, to conduct second trimester aspiration abortions is proposed as a way to increase women's access to safe abortion procedures and has been highlighted by the WHO as an area in which rigorous research is needed (WHO task-sharing guidelines). The investigators seek to conduct a comparative study of patients undergoing second trimester medical abortion provided by either physicians or nurse midwives. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02745093 -
Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks
|
Phase 4 | |
| Completed |
NCT02570204 -
Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests
|
N/A | |
| Completed |
NCT01487213 -
Routine Follow-up Versus Self-assessment in Medical Abortion
|
N/A | |
| Terminated |
NCT05119439 -
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
|
Phase 4 | |
| Terminated |
NCT04941443 -
Methadone and Medication Abortion
|
Phase 4 | |
| Completed |
NCT02985229 -
Acceptability and Feasibility of Medical Abortion in Singapore
|
Phase 3 | |
| Completed |
NCT01920022 -
Quickstart of Nexplanon® at Medical Abortion
|
Phase 4 | |
| Completed |
NCT00472394 -
Determining Women's Preferences for Medical Abortion Using Willingness to Pay
|
N/A | |
| Completed |
NCT03604341 -
Cannabinoids for Pain Control During Medical Abortion
|
Phase 4 | |
| Completed |
NCT00907725 -
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
|
N/A | |
| Completed |
NCT00120224 -
De-Medicalizing Mifepristone Medical Abortion
|
N/A | |
| Completed |
NCT03148587 -
Medical Abortion Self-Confirmation (MASC)
|
N/A | |
| Completed |
NCT00621543 -
Insertion of an Intrauterine Device (IUD) After Medical Abortion
|
N/A | |
| Completed |
NCT02343913 -
Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan
|
N/A | |
| Completed |
NCT01856777 -
Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy
|
N/A | |
| Recruiting |
NCT00920465 -
Treatment Regimens for Mifegyne and Cytotec
|
Phase 3 | |
| Completed |
NCT05532085 -
Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
|
||
| Completed |
NCT00997347 -
The Extended Gestational Age Medical Abortion Study
|
Phase 4 | |
| Completed |
NCT03014193 -
Simplifying First Trimester Medical Abortion Follow-up
|
N/A | |
| Recruiting |
NCT04905251 -
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
|